|
|
||||||||
Published online before print September 19, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
RI signals
,
,
,
,
,
,
@
*Department of Pathology, Stanford University School of Medicine, Stanford, California, USA;
Department of Allergy and Immunology, National Research Institute for Child Health & Development, Tokyo, Japan;
Division of Molecular Cell Immunology and Allergology, Advanced Medical Research Center, Nihon University Graduate School of Medical Sciences, Tokyo, Japan;
Atopy Research Center, Juntendo University, Tokyo, Japan; ||Department of Respiratory Medicine, National Disaster Medical Center of Japan, Tokyo, Japan; and ¶Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
@ To whom correspondence should be addressed. E-mail: sgalli{at}stanford.edu.
| Abstract |
|---|
The IL-1-related molecules, IL-1 and IL-18, can promote Th2 cytokine production by IgE/antigen-Fc
RI-stimulated mouse mast cells. Another IL-1-related molecule, IL-33, was identified recently as a ligand for T1/ST2. Although mouse mast cells constitutively express ST2, the effects of IL-33 on mast cell function are poorly understood. We found that IL-33, but not IL-1
or IL-18, induced IL-13 and IL-6 production by mouse bone marrow-derived, cultured mast cells (BMCMCs) independently of IgE. In BMCMCs incubated with the potently cytokinergic SPE-7 IgE without specific antigen, IL-33, IL-1
, and IL-18 each promoted IL-13 and IL-6 production, but the effects of IL-33 were more potent than those of IL-1
or IL-18. IL-33 promoted cytokine production via a MyD88-dependent but Toll/IL-1R domain-containing adaptor-inducing IFN-
-independent pathway. By contrast, IL-33 neither induced nor enhanced mast cell degranulation. At 200 ng/ml, IL-33 prolonged mast cell survival in the absence of IgE and impaired survival in the presence of SPE-7 IgE, whereas at 100 ng/ml, IL-33 had no effect on mast cell survival in the absence of IgE and reduced mast cell survival in the presence of IgE. These observations suggest potential roles for IL-33 in mast cell- and Th2 cytokine-associated immune responses and disorders.
Key Words: cytokines Fc receptors mast cells/basophils allergy
This article has been cited by other articles:
![]() |
C. A. Hudson, G. P. Christophi, R. C. Gruber, J. R. Wilmore, D. A. Lawrence, and P. T. Massa Induction of IL-33 expression and activity in central nervous system glia J. Leukoc. Biol., September 1, 2008; 84(3): 631 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xu, H.-R. Jiang, P. Kewin, Y. Li, R. Mu, A. R. Fraser, N. Pitman, M. Kurowska-Stolarska, A. N. J. McKenzie, I. B. McInnes, et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells PNAS, August 5, 2008; 105(31): 10913 - 10918. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Humphreys, D. Xu, M. R. Hepworth, F. Y. Liew, and R. K. Grencis IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes J. Immunol., February 15, 2008; 180(4): 2443 - 2449. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |